NCT04585308View on ClinicalTrials.gov

transShield Embolic Protection System Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

March 13, 2023

Study Completion Date

March 13, 2023

Conditions
Aortic Stenosis
Interventions
DEVICE

transShield Embolic Protection System

Used for embolic protection during TAVR.

Trial Locations (4)

1061

Policlinica Metropolitana, C.A, Miranda

1142

Auckland City Hospital, Auckland

3002

Ascardio Asociación Cardiovascular Centroccidental, La Lara

3204

Waikato Hospital, Hamilton

All Listed Sponsors
lead

TransAortic Medical, Inc.

INDUSTRY

NCT04585308 - transShield Embolic Protection System Feasibility Study | Biotech Hunter | Biotech Hunter